Caroline Chen covers health care for ProPublica. She is currently reporting on the coronavirus pandemic.
Her 2019 stories on a heart transplant program in New Jersey that prioritized metrics over patient care won the Livingston Award for local reporting. Her story on racial disparities in cancer clinical trials with Riley Wong in 2018 won the June L. Biedler Cancer Prize for Cancer Journalism in online/multimedia reporting.
Previously, she worked at Bloomberg News, where her coverage included the unraveling of blood test maker Theranos and the 2014 Ebola outbreak. She received her Master’s degree from the Stabile Program in Investigative Journalism at Columbia University, where she was awarded a Pulitzer Traveling Fellowship.
Las personas que reúnen los requisitos para recibir la vacuna contra el coronavirus nos dicen que se están topando con barreras que están diseñadas en los mismos sistemas destinados a atender a las personas con mayor riesgo de morir por la enfermedad. Tenemos previsto continuar el seguimiento de estos obstáculos.
People eligible for the coronavirus vaccine tell us they are running up against barriers that are designed into the very systems meant to serve those most at risk of dying of the disease. We plan to continue tracking these roadblocks.
For this to happen by the start of the next school year, trials need to prove the vaccine is safe and effective in children. Experts say manufacturers aren’t moving quickly enough, and that this is important for achieving herd immunity and stopping the spread of variants.
Governors continue to open indoor dining and other activities before vaccinations become widespread. Experts warn this could create superspreading playgrounds for dangerous variants and squander our best shot at getting the pandemic under control.
The CDC says health facilities should report unused and spoiled COVID-19 vaccines, but many are failing to do so. At a time when there aren’t enough shots to meet demand, significant numbers may be going in the trash.
States are struggling to plan their vaccination programs with just one week’s notice for how many doses they’ll receive from the federal government. The incoming Biden administration is deciding what to do with this dysfunctional system.
Stanford Medicine officials relied on a faulty algorithm to determine who should get vaccinated first, and it prioritized some high-ranking doctors over patient-facing medical residents.
States and the federal government also don’t reliably collect data so we won’t have a good idea of whether the vaccine is reaching these critical populations.
Health care workers don’t need patronizing praise. They need resources, federal support, and for us to stay healthy and out of their hospitals. In many cases, none of that is happening.
A review of state distribution plans reveals that officials don’t know how they’ll deal with the difficult storage and transport requirements of Pfizer’s vaccine, especially in the rural areas currently seeing a spike in infections.
En una elección histórica marcada por una pandemia, el voto por correo y la desinformación, los funcionarios electorales se esfuerzan por adaptarse. Esto es lo que los reporteros nacionales de ProPublica están viendo en todo el país. El artículo será actualizado a lo largo del día
In a historic election shaped by a pandemic, mail-in voting and misinformation, election officials are scrambling to adapt. Here’s what ProPublica’s national reporters are seeing across the country. This post will be updated throughout the day.
Dr. Mark Zucker was put on administrative leave after ProPublica showed he told staff to keep a heart transplant patient on life support because of concerns about survival stats. Now Newark Beth Israel will seek a new leader for the program.
Dr. Anthony Fauci will see data from government-funded vaccine trials before the FDA does. One caveat: Pfizer’s study, which is ahead of the others, isn’t included in his purview.
There is a small chance that Pfizer’s vaccine trial will yield results by Nov. 3. But it could still take weeks for FDA review. Here’s everything that has to happen and how to tell a political stunt from a real vaccine.
While it battles a virus that can spread quickly via silent carriers, the United States has yet to execute a strategy for testing asymptomatic people. This is a problem — and ProPublica health reporter Caroline Chen explains why.
ProPublica está cubriendo la reapertura de escuelas, colegios superiores y universidades durante COVID-19 y necesitamos su ayuda. Cuéntenos acerca de la seguridad, el ámbito académico, las colegiaturas y el acceso al aprendizaje.
ProPublica is covering school, college and university reopenings during COVID-19, and we need your help. Tell us about safety, academics, tuition and access to learning.
Viewed in isolation or presented without context, coronavirus numbers don’t always give an accurate picture of how the pandemic is being handled. Here, ProPublica journalists Caroline Chen and Ash Ngu offer insight on how to navigate the figures.
Thank you for your interest in republishing this story. You are are free to republish it so long as you do the following:
You have to credit us. In the byline, we prefer “Author Name, ProPublica.” At the top of the text of your story, include a line that reads: “This story was originally published by ProPublica.” You must link the word “ProPublica” to the original URL of the story.
If you’re republishing online, you must link to the URL of this story on propublica.org, include all of the links from our story, including our newsletter sign up language and link, and use our PixelPing tag.
If you use canonical metadata, please use the ProPublica URL. For more information about canonical metadata, refer to this Google SEO link.
You can’t edit our material, except to reflect relative changes in time, location and editorial style. (For example, “yesterday” can be changed to “last week,” and “Portland, Ore.” to “Portland” or “here.”)
You cannot republish our photographs or illustrations without specific permission. Please contact [email protected].
It’s okay to put our stories on pages with ads, but not ads specifically sold against our stories. You can’t state or imply that donations to your organization support ProPublica’s work.
You can’t sell our material separately or syndicate it. This includes publishing or syndicating our work on platforms or apps such as Apple News, Google News, etc.
You can’t republish our material wholesale, or automatically; you need to select stories to be republished individually. (To inquire about syndication or licensing opportunities, contact our Vice President of Business Development, Celeste LeCompte.)
You can’t use our work to populate a website designed to improve rankings on search engines or solely to gain revenue from network-based advertisements.
We do not generally permit translation of our stories into another language.
Any website our stories appear on must include a prominent and effective way to contact you.
If you share republished stories on social media, we’d appreciate being tagged in your posts. We have official accounts for ProPublica and ProPublica Illinois on both Twitter (@ProPublica and @ProPublicaIL) and Facebook.
Copy and paste the following into your page to republish:
